Acceleron Pharma, Inc.
| Article | Date | Source |
|---|
| Acceleron Pharma Closes $30.5M Offering - cbl | January 05, 2012 | Biotechnology - Moreover |
| Acceleron Pharma Secures $30 Million Private Financing | December 28, 2011 | BioSpace |
| Acceleron Pharma raises $30M strategic financing | December 23, 2011 | Health News - BizJournals.com |
| Acceleron Pharma to Present at Two Upcoming Investor Conferences | November 28, 2011 | Pharma News - Business Wire |
| Acceleron Pharma nitiates Phase 1 Study of ACE-5 | September 13, 2011 | Biotechnology - Moreover |
| Acceleron Pharma to Present at Two September Investor Conferences | September 12, 2011 | Pharma News - Business Wire |
| Acceleron Pharma Announces Global Collaboration with Celgene Corporation on ACE-536 Program | August 03, 2011 | Pharma News - Business Wire |
| Acceleron Pharma Leverages Single-Use Technology and Capable Suppliers to Meet Their Goals | July 14, 2011 | Pharmaceutical - Moreover |
| Celgene and Acceleron Pharma Initiate Phase 2/3 Study of ACE-011 (sotatercept) to Treat Chemotherapy-Induced Anemia in Patients with Lung Cancer | June 02, 2011 | BioSpace - Breaking News |
| Acceleron Pharma Presents Anabolic Bone Effects of ACE-661 at International Scientific Meeting | May 09, 2011 | Pharma News - Business Wire |
| Acceleron Pharma to Present at Two Upcoming Investor Conferences in April | March 30, 2011 | Biotech News - Business Wire |
| Acceleron Pharma to Present at the 29th Annual J.P. Morgan Healthcare Conference | January 05, 2011 | Pharma News - Business Wire |
| Acceleron Pharma Announces Departure of Jasbir Seehra, Ph.D. Chief Scientific Officer | November 19, 2010 | Pharma News - Business Wire |
| Acceleron Pharma Announces Interim Findings from the ACE-041 Phase 1, First-in-Human Clinical Trial at 22nd European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium on Molecular Targets and Cancer Therapeutics | November 19, 2010 | BioSpace - Breaking News |
| Acceleron Pharma Cuts 40 Percent of Workforce | November 03, 2010 | Xconomy Life Sciences |
| Acceleron Pharma Says It Cut | November 03, 2010 | Biotechnology - Moreover |
| Acceleron Pharma Says It Cut 57 Employees | November 03, 2010 | BioSpace |
| Acceleron Pharma Presents Preliminary ACE-031 Results from a Phase 1 Multiple Ascending Dose Study in Healthy Volunteers | October 13, 2010 | BioSpace - Breaking News |
| FierceBiotech Names Acceleron Pharma as One of the “Fierce 15” of 2010 | September 15, 2010 | Pharma News - Business Wire |
| Acceleron Pharma and Shire announce joint venture | September 09, 2010 | Biotechnology - Moreover |
| Acceleron Pharma Announces Joint Development and Commercialization Agreement with Shire plc on Novel Muscle Therapeutics for Orphan Diseases in Deal Worth up to $498 Million | September 09, 2010 | BioSpace |
| Acceleron Pharma Announces Joint Development and Commercialization Agreement with Shire plc on Novel Muscle Therapeutics for Orphan Diseases; to Make Upfront Payment of $45 Million with Potential for Additional $288 Million | September 09, 2010 | BioSpace |
| Acceleron Pharma Announces Joint Development and Commercialization Agreement with Shire on Novel Muscle Therapeutics for Orphan Diseases | September 09, 2010 | Pharma News - Business Wire |
| Acceleron Pharma Pharma Receives FDA Orphan Designation for ACE-031 for the Treatment of Duchenne Muscular Dystrophy | August 19, 2010 | BioSpace - Breaking News |
| Acceleron Pharma Receives FDA Orphan Designation for ACE-031 for the Treatment of Duchenne Muscular Dystrophy | August 19, 2010 | FDA News - Business Wire |
| Acceleron Pharma Receives FDA Fast Track Designation for ACE-031 for the Treatment of Duchenne Muscular Dystrophy | August 04, 2010 | FDA News - Business Wire |
| Acceleron Pharma Initiates Phase 2 Clinical Trial with ACE-031 in Patients with Duchenne Muscular Dystrophy | May 05, 2010 | Pharma News - Business Wire |
| Acceleron Pharma Recognized by The Wall Street Journal as One of the Top 50 Venture-Backed Companies in the United States | March 10, 2010 | BioSpace - Breaking News |
| Acceleron Pharma Announces Addition of Two Novel Programs to Development Pipeline at the 28th Annual JP Morgan Healthcare Conference | January 14, 2010 | Pharma News - Business Wire |
| Acceleron Pharma to Present at the 28th Annual J.P. Morgan Healthcare Conference | January 07, 2010 | Pharma News - Business Wire |
| Acceleron Pharma Reports $10.9M Financing | December 16, 2009 | Xconomy Life Sciences |
| Acceleron Pharma Invests in Bricks & Mortar When Virtual is In Vogue | December 10, 2009 | Xconomy Life Sciences |
| Alkermes Inks $10M Licensing Deal with Acceleron Pharma | December 04, 2009 | BioSpace |
| Acceleron Pharma Expands Management Team with Two New Appointments | | Pharma News - Business Wire |
| Acceleron Pharma Presents Findings of ACE-536, a Novel Red Blood Cell-Forming Agent, at the 51st Annual Meeting of the American Society of Hematology | | Pharma News - Business Wire |
| Acceleron Pharma to Present Data on ACE-011 and ACE-536 at the 51st Annual Meeting of the American Society of Hematology | | Pharma News - Business Wire |
